Professional paper
https://doi.org/10.15836/ccar2018.526
In the heart of hypertension treatment: single-pill combinations containing a renin-angiotensin-aldosterone system blocker.
Teja Prijatelj
; Krka, d.d., Novo mesto Slovenia
Breda Barbič-Žagar
orcid.org/0000-0002-1173-7361
; Krka d.d., Novo mesto, Slovenia
Abstract
Although the awareness and control of hypertension have increased, improved achievement rates for target blood pressure (BP) levels remain an unmet need worldwide. Due to a multifactorial etiology of hypertension, BP targets cannot be reached with a single agent in most patients. Low adherence to antihypertensive treatment, which is in direct correlation with the number of medications prescribed, has been recognized as a major contributor to poor BP control. The need to improve BP control is reflected in the 2018 ESC/ESH Guidelines for the management of arterial hypertension, which developed a simple and pragmatic treatment strategy for a more effective and faster lowering of BP to target levels – the most important issue in the management of hypertension.
Keywords
target blood pressure; adherence; guidelines; combination therapy; single-pill combination.
Hrčak ID:
210147
URI
Publication date:
29.11.2018.
Visits: 4.279 *